Clinical Trial Update: Dose Dense Adjuvant CMF (Cyclophosphamide, Methotrexate, Fluorouracil) at 14 and 10-11 Day Intervals for Women With Early Stage Breast Cancer [NA]

View source ↗

Summary

A completed clinical trial evaluating dose-dense adjuvant CMF (cyclophosphamide, methotrexate, fluorouracil) regimens in women with early-stage breast cancer. T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• FLUOROURACIL (Fluorouracil)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Breast Cancer | NA | Status: COMPLETED | Results posted: 2017-03-03